# Eliglustat on Gaucher Disease Type IIIB

> **NCT03519646** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 4 (actual)

## Conditions studied

- Gaucher Disease, Type III

## Interventions

- **DRUG:** Eliglustat

## Key facts

- **NCT ID:** NCT03519646
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2020-09-11
- **Final completion:** 2020-09-11
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2022-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03519646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03519646, "Eliglustat on Gaucher Disease Type IIIB". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03519646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*